Recent advancements in diabetes therapy have introduced a new class of drugs known as GLP-1 receptor agonists. These medications, which mimic the effects of a naturally occurring hormone called glucagon-like peptide-1 https://myafuiv568573.thechapblog.com/37746048/emerging-treatments-for-type-2-diabetes